Annual CFI
-$62.85 M
-$62.82 M-261766.67%
December 31, 2024
Summary
- As of March 12, 2025, NAMS annual cash flow from investing activities is -$62.85 million, with the most recent change of -$62.82 million (-261766.67%) on December 31, 2024.
- During the last 3 years, NAMS annual CFI has fallen by -$62.82 million (-261766.67%).
- NAMS annual CFI is now -392700.00% below its all-time high of -$16.00 thousand, reached on December 1, 2020.
Performance
NAMS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$62.18 M
-$62.10 M-82805.33%
December 31, 2024
Summary
- As of March 12, 2025, NAMS quarterly cash flow from investing activities is -$62.18 million, with the most recent change of -$62.10 million (-82805.33%) on December 31, 2024.
- Over the past year, NAMS quarterly CFI has dropped by -$62.10 million (-82805.33%).
- NAMS quarterly CFI is now -2072533.33% below its all-time high of -$3000.00, reached on December 31, 2023.
Performance
NAMS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$62.85 M
-$62.18 M-9252.38%
December 31, 2024
Summary
- As of March 12, 2025, NAMS TTM cash flow from investing activities is -$62.85 million, with the most recent change of -$62.18 million (-9252.38%) on December 31, 2024.
- Over the past year, NAMS TTM CFI has dropped by -$62.18 million (-9252.38%).
- NAMS TTM CFI is now -897728.57% below its all-time high of -$7000.00, reached on March 31, 2023.
Performance
NAMS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
NAMS Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10000.0% | -10000.0% | -9252.4% |
| 3 y3 years | -10000.0% | -10000.0% | -9252.4% |
| 5 y5 years | -10000.0% | -10000.0% | -9252.4% |
NAMS Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | <-9999.0% | at low | <-9999.0% | at low | <-9999.0% | at low |
| 5 y | 5-year | <-9999.0% | at low | <-9999.0% | at low | <-9999.0% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low | <-9999.0% | at low |
NewAmsterdam Pharma Company NV Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$62.85 M(>+9900.0%) | -$62.18 M(>+9900.0%) | -$62.85 M(+9252.4%) |
| Sep 2024 | - | -$75.00 K(-64.1%) | -$672.00 K(+10.9%) |
| Jun 2024 | - | -$209.00 K(-45.7%) | -$606.00 K(+50.7%) |
| Mar 2024 | - | -$385.00 K(>+9900.0%) | -$402.00 K(+1575.0%) |
| Dec 2023 | -$24.00 K | -$3000.00(-66.7%) | -$24.00 K(+14.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$9000.00(+80.0%) | -$21.00 K(+75.0%) |
| Jun 2023 | - | -$5000.00(-28.6%) | -$12.00 K(+71.4%) |
| Mar 2023 | - | -$7000.00 | -$7000.00 |
| Dec 2022 | -$221.00 K(+820.8%) | - | - |
| Dec 2021 | -$24.00 K(+50.0%) | - | - |
| Dec 2020 | -$16.00 K | - | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual cash flow from investing activities?
- What is the all time high annual CFI for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual CFI year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly CFI year-on-year change?
- What is NewAmsterdam Pharma Company NV TTM cash flow from investing activities?
- What is the all time high TTM CFI for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV TTM CFI year-on-year change?
What is NewAmsterdam Pharma Company NV annual cash flow from investing activities?
The current annual CFI of NAMS is -$62.85 M
What is the all time high annual CFI for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual cash flow from investing activities is -$16.00 K
What is NewAmsterdam Pharma Company NV annual CFI year-on-year change?
Over the past year, NAMS annual cash flow from investing activities has changed by -$62.82 M (-261766.67%)
What is NewAmsterdam Pharma Company NV quarterly cash flow from investing activities?
The current quarterly CFI of NAMS is -$62.18 M
What is the all time high quarterly CFI for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly cash flow from investing activities is -$3000.00
What is NewAmsterdam Pharma Company NV quarterly CFI year-on-year change?
Over the past year, NAMS quarterly cash flow from investing activities has changed by -$62.10 M (-82805.33%)
What is NewAmsterdam Pharma Company NV TTM cash flow from investing activities?
The current TTM CFI of NAMS is -$62.85 M
What is the all time high TTM CFI for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high TTM cash flow from investing activities is -$7000.00
What is NewAmsterdam Pharma Company NV TTM CFI year-on-year change?
Over the past year, NAMS TTM cash flow from investing activities has changed by -$62.18 M (-9252.38%)